Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Protesters Disrupt Democrats' Best-Laid Plans For Health Reform 'Conversations'
Over the weekend, a series of protests at Democratic events meant to promote health reform "organized by loose-knit coalition of conservative voters and advocacy groups, were a raucous start to what is expected to be weeks of political and ideological clashes over the health care overhaul," the New York Times reports. "Republicans said that the protests were just the beginning of spontaneous opposition to the health care proposals and that they would only gain momentum as Americans learn more about the legislation." But Democrats said they were only an effort to block discourse, and were anything but a grass-roots campaign. "This is a very coordinated effort," said one Democratic Congressman who was confronted by protestors at a grocery store (Herszenhorn and Stolberg, 8/3).
generic viagra online
$90 Million In Recovery Act Funds To Bolster Water Services In Indian Country And Create Jobs
The U.S. Environmental Protection Agency (EPA) and the U.S. Department of Health and Human Service"s (HHS) Indian Health Service (IHS) announced $90 million in funds from the American Recovery and Reinvestment Act of 2009 for improved access to vital drinking water and wastewater services in the American Indian and Alaska Native communities. The funds will be invested in "shovel ready" infrastructure projects designed to better protect human and environmental health in Indian Country and to create jobs.
News of the day
New Health Snapshots Show States Vary Widely In Providing Quality Health Care
The Agency for Healthcare Research and Quality"s annual release of state-by-state quality data continues to give states mixed reviews for the quality of care they provide. As in previous years, AHRQ"s 2008 State Snapshots show that no state does well or poorly on all quality measures.
Health Insurance

Forsyth Medical Center Participating In Avastin Trial For New Glioblastoma Patients

The Derrick L. Davis Forsyth Regional Cancer Center at Forsyth Medical Center is participating in a national trial of the experimental drug Avastin to treat glioblastoma, a fast-growing tumor of the brain or spinal cord. Forsyth Regional Cancer Center (FRCC) is participating in the third phase of the trial, testing the effectiveness of Avastin in conjunction with standard chemotherapy and radiation treatments for patients newly diagnosed with glioblastoma. This phase of the trial will enroll 700 participants nationwide, and FRCC is one of the first sites in the country to participate. The trial is part of the hospital"s neurosciences program. "Avastin has been shown to be effective in treating various types of cancer, with a low risk of serious side effects, so our hope is that it will improve outcomes for patients with brain tumors when it is added to standard-of-care treatments," says Volker Stieber, M.D., a radiation oncologist at the FRCC. "Phase III is the highest level of research for a drug, so we are excited to be part of a study that could advance treatment for patients with this type of cancer." In May, the U.S. Food and Drug Administration approved the use of Avastin to treat glioblastomas that have not responded to other therapies based on results from two Phase II studies that showed Avastin reduced tumor size in some glioblastoma patients. The new study evaluates this drug in newly diagnosed, never-treated glioblastoma patients. Glioblastoma is the most common and most aggressive type of primary brain tumor in humans, accounting for about half of all primary brain tumor cases. Despite its prevalence, however, glioblastomas occur in only two to three cases per 100,000 people in North America and Europe. In Forsyth County, three out of four patients diagnosed with glioblastoma are diagnosed at Forsyth Medical Center. The FRCC is currently screening patients for enrollment in the clinical trial. Eligible patients may qualify if they are newly diagnosed adults able to undergo partial removal of their tumors. Once enrolled, participants will remain in the study for up to one year. Freda Springs Forsyth Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009